SCM
TMO icon

Sandler Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Sandler Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,000
Closed -$3.09M – 204
2024
Q3 		$3.09M Sell
5,000
-6,560
-57% -$3.88M 0.41% 90
2024
Q2 		$6.39M Buy
+11,560
New +$6.62M 0.68% 56
2022
Q3 		– Sell
-15,600
Closed -$8.47M – 111
2022
Q2 		$8.47M Buy
+15,600
New +$8.59M 0.9% 47
2021
Q4 		– Sell
-10,000
Closed -$5.71M – 133
2021
Q3 		$5.71M Buy
+10,000
New +$5.49M 0.51% 71
2020
Q4 		– Sell
-25,900
Closed -$11.4M – 95
2020
Q3 		$11.4M Sell
25,900
-21,111
-45% -$8.72M 1.15% 34
2020
Q2 		$17M Buy
47,011
+1,011
+2% +$339K 1.62% 20
2020
Q1 		$13M Buy
46,000
+26,666
+138% +$8.41M 1.8% 16
2019
Q4 		$6.28M Sell
19,334
-22,678
-54% -$6.88M 0.72% 52
2019
Q3 		$12.2M Sell
42,012
-48,275
-53% -$13.8M 1.07% 39
2019
Q2 		$26.5M Buy
90,287
+25,751
+40% +$7.09M 1.77% 12
2019
Q1 		$17.7M Buy
64,536
+38,970
+152% +$9.7M 1.37% 21
2018
Q4 		$5.72M Sell
25,566
-76,761
-75% -$18M 0.48% 58
2018
Q3 		$25M Buy
+102,327
New +$23.5M 1.26% 22
2016
Q3 		– Sell
-46,890
Closed -$6.93M – 140
2016
Q2 		$6.93M Buy
+46,890
New +$6.92M 0.91% 43
2016
Q1 		– Sell
-36,200
Closed -$5.13M – 167
2015
Q4 		$5.13M Sell
36,200
-6,100
-14% -$814K 0.49% 80
2015
Q3 		$5.17M Buy
+42,300
New +$5.51M 0.6% 59

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sandler Capital Management's TMO Position: Q4 2024 in Review

Sandler Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 5,000 shares — an estimated $3.09M sold.

Sandler Capital Management first reported a position in TMO in Q3 2015 and held it in 16 quarters. The position peaked at $26.5M in Q2 2019. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Sandler Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Sandler Capital Management sold 5,000 Thermo Fisher Scientific shares in Q4 2024, an estimated $3.09M.
  • Sandler Capital Management first reported a position in Thermo Fisher Scientific in Q3 2015 and held it in 16 quarters.
  • Sandler Capital Management's Thermo Fisher Scientific position peaked at $26.5M in Q2 2019.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Sandler Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.